Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06515392

TIA Scores' Mortality Predictions and Recurrent TIA and Stroke Prediction

Our study adopts a prospective design. Our research aims to determine the significance of ABCD2, ABCD3-I, Canadian TIA Score, and NIHSS Score in predicting the likelihood of ischemic stroke within 30 days in patients presenting to the emergency department with transient ischemic attack (TIA)

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Etlik City Hospital

Ankara, Yenimahalle, 06170, Turkey (Türkiye)

Location status: Recruiting

Location contact

bedriye muge sonmez, ass.prof.

SUB_INVESTIGATOR

gulsen akcay, ass. prof

PRINCIPAL_INVESTIGATOR

gulsen akcay, ass. prof.

CONTACT

[email protected]

+905052874949

sefika ceren ture, resident

SUB_INVESTIGATOR

tugba sanalp menekse, specialist

SUB_INVESTIGATOR

About this study

Our study is planned as follows: Patients diagnosed with transient ischemic attack (TIA) presenting to the emergency department will undergo scoring by researchers, although they will not intervene the treatment process of the patients. Patients will be contacted by researchers or their families to ascertain whether they experience a recurrent stroke or TIA within 30 days, and their current health status will be assessed. The collected information will be recorded.

The study will include patients diagnosed with transient ischemic attack (TIA) based on tests and imaging conducted at Ankara Etlik City Hospital's emergency department. The planned duration for data collection and analysis is one year.

Parameters to be examined:

Age Gender Physical examination findings Comorbidities (hypertension, coronary artery disease, valvular heart disease, COPD, asthma, diabetes, others) Neurological examination findings Time of symptom onset Admission status (intensive care unit / ward) Findings from ultrasound, computed tomography, and MRI imaging Length of hospital stay Mortality (yes/no)

We aim to collect data from approximately 300 patients within the course of one year for our study

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Patients presenting to the emergency department and diagnosed with TIA Patients diagnosed with ischemic stroke who did not receive thrombolytic therapy based on NIHSS score Patients aged 18 and above Patients who consented by signing the informed consent form

Exclusion criteria

Patients diagnosed with hemorrhagic stroke Patients unwilling to participate in the study Patients with a history of trauma Patients unable to receive thrombolytic therapy for any reason (trauma, malignancy, etc.) Patients under the age of 18 Patients transferred from another hospital Patients who experienced cardiac arrest Patients who died for any reason other than ischemic stroke within 30 days Patients wishing to withdraw from the study at any time during the study period

Treatment and study plan

Primary outcomes

  1. recurrent TIA or stroke

    Time frame: 30 days

    recurrent TIA within 30 days of follow-up

Study contacts

Contact information is provided by the study sponsor or research team.

gulsen akcay, ass. prof.

CONTACT

[email protected]

+905052874949

Sponsors and collaborators

Lead sponsor

Saglik Bilimleri Universitesi

Other

Collaborators

  • Ankara Etlik City Hospital

Registry information

Official study title

The Role of TIA Scores and NIHSS Score in Predicting Early and Late Ischemic Stroke Risk in Patients Presenting With Transient Ischemic Attack to the Emergency Department

Important dates

Study start
2024
Primary completion
2025
Study completion
2025
First posted
Jul 23, 2024
Registry last updated
Jul 23, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.